Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of changes, notices of special interest NOSI, and funding opportunities.
Policy Notices
- Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs
National Institutes of Health
- Reminder: NIH Natural Disaster Policy Hurricane Laura
National Institutes of Health
General Notices
- Pre-Application Webinar for RFA-CA-20-040, Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)
National Cancer Institute
- NIMHD Loan Repayment Program Technical Assistance Webinar
National Institute on Minority Health and Health Disparities
- Reissue of Parent Research Supplements to Promote Diversity in Health-Related Research FOA in October 2020
National Institutes of Health
- Notice of Limited Availability of Research Non-human Primates
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Updated Information on the Research Projects Component for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
National Institute for Occupational Safety and Health
Notice of Changes to Funding Opportunities
- Notice of Expiration of PAR-18-923 - Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Notice of Expiration of PAR-19-307 " Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)"
National Institute of Allergy and Infectious Diseases
- Notice of Extension of the Expiration Date for PAR-18-337 "NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08, No Independent Clinical Trials)"
National Cancer Institute
- Notice of Extension of the Expiration Date for PAR-18-364 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)"
National Cancer Institute
- Notice of Extension of the Expiration Date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)"
National Cancer Institute
- Notice of Extension of the Expiration Date for PAR-18-366 "NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials)"
National Cancer Institute
- Notice of Extension of the Expiration Date for PAR-18-367 "NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)"
National Cancer Institute
- Notice of Change to Application Due Date for RFA-DA-21-009, "Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)"
National Institute on Drug Abuse
- NOTICE of eligibility change for PAR-18-901: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)
John E. Fogarty International Center
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest: Alzheimers-focused administrative supplements for NIH grants that are not focused on Alzheimers disease
National Institute on Aging
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Training Modules for Creating Safe, Inclusive, and Supportive Research Environments
National Institute of General Medical Sciences
- Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Special Interest (NOSI): Palliative Care in Heart, Lung, Blood, and Sleep Diseases
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Research in the Emergency Setting
National Institute of Neurological Disorders and Stroke
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
- Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)
National Institute of Neurological Disorders and Stroke
Funding Opportunities
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
National Institute of Mental Health
- Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed)
National Institute of General Medical Sciences
- Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
- NIEHS SBIR Phase IIB Validation of Sensors for Improved Environmental Exposure Assessment (R44 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu